IBD Risk ‘Uncertain’ in Biologic-Treated Patients With AxSpA

'Enormous uncertainty' surrounds the risk of inflammatory bowel disease associated with biologic treatment in patients with axial spondyloarthritis.
Medscape Medical News
‘Enormous uncertainty’ surrounds the risk of inflammatory bowel disease associated with biologic treatment in patients with axial spondyloarthritis.
Medscape Medical News